Medtronic Launches the Avalus Ultra Valve Engineered for Ease of Use at Implant and Lifetime Patient Management
April 23, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. This next-generation surgical aortic tissue valve is designed to facilitate ease of use at implant and lifetime patient management. It’s an excellent choice for cardiac surgeons and their patients seeking an aortic valve solution that can be fit for the future, right from the start. The Avalus Ultra valve is engineered for ease of implant, clear visibility for future valve-in-valve procedures, and straightforward sizing. More specifically, the Avalus Ultra surgical valve has: A low valve profile designed to facilitate ease of use at implant.1,2 A polyetheretherketone (PEEK) base frame, which provides consistent circularity3, 4 An industry-leading Effective Orifice Area (EOA) that may allow for greater blood flow that is supported by the clinical evidence of the Avalus™ valve 5,6 A radiopaque coil for clear visibility f